^ Back to Top

Cancer care

Lung cancer follow-up and surveillance: the role of primary care

Transitioning from active treatment to post-treatment care is an important milestone in the long-term health of people who have... View Article

October 2021

Surveillance for people with polyps or inflammatory bowel disease

Guidance for following up people who have had polyps identified on colonoscopy and people with inflammatory bowel disease, who... View Article

August 2021

Follow-up and surveillance for people after treatment for bowel cancer

Bowel cancer is a leading cause of cancer mortality in New Zealand, second only to lung cancer. Follow-up and surveillance of... View Article

August 2021

Cancer care: the role of primary care in identifying and managing cachexia

Through improvements in diagnosis and treatment, one in three people in New Zealand with cancer now achieve sustained remission... View Article

April 2021

Early detection of lung cancer in primary care

Lung cancer is one of the most common cancers in New Zealand and the leading cause of cancer death. By the time of diagnosis,... View Article

March 2021

National report: Testing for prostate cancer in primary care

This report provides an overview of laboratory prostate-specific antigen (PSA) testing in primary care to facilitate reflection,... View Article

July 2020

Peer group discussion: Referral for patients with suspected bowel cancer

The following questions can be used as discussion points for peer groups or self-reflection of practice. The questions for this... View Article

February 2020

Referral of patients with features suggestive of bowel cancer: Ministry of Health guidance

Bowel cancer is one of the most common causes of cancer death in New Zealand. Approximately one-quarter of diagnoses are made... View Article

February 2020

Testing for prostate cancer: helping patients to decide

Testing for prostate cancer is a difficult issue as many prostate cancers are low risk and do not necessarily result in adverse... View Article

February 2020

Reducing the burden of melanoma in New Zealand Part 2: Early detection of melanoma

Identification of melanoma at the earliest possible clinical stage improves outcomes; lesion thickness is the strongest predictor... View Article

January 2020

Reducing the burden of melanoma in New Zealand Part 1: Prevention and risk assessment

Limiting UV radiation exposure through sun smart behaviour is the key to preventing melanoma. However, incidence and mortality... View Article

January 2020